A $45 million jury verdict is bad enough. Getting nearly a half-billion dollars knocked off your market cap—and almost $200 million added to your competitor’s—might be even worse.

That was the market fallout Tuesday for molecular diagnostic company Natera Inc. after losing a five-day jury trial to competitor CareDx Inc. over false advertising and unfair competition.